Opsalin: A phase II placebo (Pbo)-controlled randomized study of ombrabulin in patients with platinum-sensitive recurrent ovarian cancer (OC) treated with carboplatin (Cb) and paclitaxel (P)

被引：0
|
作者：
Birrer, Michael J.
Bondarenko, Igor
Tjulandin, Sergei
Vergote, Ignace
Cibula, David
Ray-Coquard, Isabelle
Colombo, Nicoletta
Allard, Aurore
Oprea, Corina
Rey, Augustin A.
Sessa, Cristiana
Pujade-Lauraine, Eric
机构：
[1] Massachusetts Gen Hosp, Dana Farber Harvard Canc Ctr, Boston, MA 02114 USA
[2] Dnipropetrovsk Med Acad, Dnepropetrovsk, Ukraine
[3] NN Blokhin Russian Canc Res Ctr, Moscow, Russia
[4] Katholieke Univ Leuven Hosp, Louvain, Belgium
[5] Charles Univ Prague, Fac Med 1, Prague, Czech Republic
[6] Ctr Leon Berard, F-69373 Lyon, France
[7] Ist Europeo Oncol, Milan, Italy
[8] Sanofi, Chilly Mazarin, France
[9] Sanofi, Vitry Sur Seine, France
[10] Ist Oncol Svizzera Italiana, Bellinzona, Switzerland
[11] Hop Hotel Dieu, F-75181 Paris, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5516
引用
收藏
页数：1
相关论文
共 50 条
  • [41] A phase I study of lapatinib in combination with carboplatin in women with recurrent platinum-sensitive ovarian carcinoma
    Kimball, K. J.
    Numnum, T. M.
    Kirby, T. O.
    Zamboni, W. C.
    Estes, J. M.
    Barnes, M. N.
    Matei, D.
    Alvarez, R. D.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S60 - S60
  • [42] Secondary Cytoreduction and Carboplatin Hyperthermic Intraperitoneal Chemotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: An MSK Team Ovary Phase II Study
    Zivanovic, Oliver
    Chi, Dennis S.
    Zhou, Qin
    Iasonos, Alexia
    Konner, Jason A.
    Makker, Vicky
    Grisham, Rachel N.
    Brown, Amy K.
    Nerenstone, Stacy
    Diaz, John P.
    Schroeder, Eric D.
    Langstraat, Carrie L.
    Paroder, Viktoriya
    Lakhman, Yulia
    Soldan, Krysten
    Su, Katy
    Gardner, Ginger J.
    Andikyan, Vaagn
    Guo, Jianxia
    Jewell, Elizabeth L.
    Roche, Kara Long
    Troso-Sandoval, Tiffany
    Lichtman, Stuart M.
    Moukarzel, Lea A.
    Dessources, Kimberly
    Abu-Rustum, Nadeem R.
    Aghajanian, Carol
    Tew, William P.
    Beumer, Jan
    Sonoda, Yukio
    O'Cearbhaill, Roisin E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (23) : 2594 - +
  • [43] Olaparib plus paclitaxel plus carboplatin (P/C) followed by olaparib maintenance treatment in patients (pts) with platinum-sensitive recurrent serous ovarian cancer (PSR SOC): A randomized, open-label phase II study.
    Oza, Amit M.
    Cibula, David
    Oaknin, Ana
    Poole, Christopher John
    Mathijssen, Ron H. J.
    Sonke, Gabe S.
    Colombo, Nicoletta
    Spacek, Jiri
    Vuylsteke, Peter
    Hirte, Hal W.
    Mahner, Sven
    Plante, Marie
    Schmalfeldt, Barbara
    Mackay, Helen
    Rowbottom, Jacqui
    Tchakov, Ilian
    Friedlander, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [44] Phase II Evaluation of Nanoparticle Albumin-Bound Paclitaxel in Platinum-Sensitive Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer
    Teneriello, Michael G.
    Tseng, Paul C.
    Crozier, Mark
    Encarnacion, Carlos
    Hancock, Kenneth
    Messing, Mark J.
    Boehm, Kristi A.
    Williams, Alicia
    Asmar, Lina
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (09) : 1426 - 1431
  • [45] Phase II trial of combination topotecan and carboplatin chemotherapy in platinum-sensitive ovarian cancer.
    Shahin, MS
    Hanjani, P
    Nolte, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 485S - 485S
  • [46] Retrospective Analysis Of Comparative Outcomes In Recurrent Platinum-Sensitive Ovarian Cancer Treated With Pegylated Liposomal Doxorubicin (Lipo-Dox) And Carboplatin Versus Paclitaxel And Carboplatin
    Weng, Chia-Sui
    Wu, Chao-Chih
    Chen, Tze-Chien
    Chen, Jen-Ruei
    Huang, Chueh-Yi
    Chang, Chih-Long
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9899 - 9905
  • [47] AN OPEN-LABEL, RANDOMIZED PHASE II STUDY ON TRABECTEDIN AND BEVACIZUMAB WITH OR WITHOUT CARBOPLATIN IN PARTIALLY PLATINUM-SENSITIVE (PPS) OVARIAN CANCER
    Gerardi, C.
    Floriani, I.
    Biagioli, E.
    D'Incalci, M.
    Fossati, R.
    Colombo, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 455 - 456
  • [48] Phase II trial of pyrazoloacridine in recurrent platinum-sensitive ovarian cancer: A Gynecologic Oncology Group study
    Plaxe, SC
    Blessing, JA
    Bookman, MA
    Creasman, WT
    GYNECOLOGIC ONCOLOGY, 2002, 84 (01) : 32 - 35
  • [49] A phase II trial of iniparib (BSI-201) in combination with gemcitabine/carboplatin (GC) in patients with platinum-sensitive recurrent ovarian cancer.
    Penson, R. T.
    Whalen, C.
    Lasonde, B.
    Krasner, C. N.
    Konstantinopoulos, P.
    Stallings, T. E.
    Bradley, C. R.
    Birrer, M. J.
    Matulonis, U.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Results of a phase II evaluation of nanoparticle albumin bound paclitaxel (nab-paclitaxel) in platinum-sensitive patients with recurrent ovarian, peritoneal, or fallopian tube cancer
    Teneriello, M. G.
    Tseng, P. C.
    Crozier, M.
    Encarnacion, C.
    Hancock, K.
    Messing, M. J.
    Boehm, K. A.
    Williams, A.
    Ilegbodu, D.
    Asmar, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345